Browse by category

The long-term use of proton pump inhibitors (PPIs), a class of drugs widely used to treat acid reflux and ulcers, may not be linked to any increased risk of developing gastric adenocarcinoma, according to a study of Nordic health data. "The results of this study do not support the hypothesis that long-term proton pump inhibitor use is associated with an increased risk of gastric adenocarcinoma,” the researchers noted. “This finding should offer relief for patients needing lon